Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Omnicell, Inc. before investing.

In this article, we go over a few key elements for understanding Omnicell, Inc.’s stock price such as:

• Omnicell, Inc.’s current stock price and volume
• Why Omnicell, Inc.’s stock price changed recently
• Upgrades and downgrades for OMCL from analysts
• OMCL’s stock price momentum as measured by its relative strength

About Omnicell, Inc. (OMCL)

Before we jump into Omnicell, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Want to learn more about Omnicell, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Omnicell, Inc..

Omnicell, Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Omnicell, Inc.’s stock price was $35.370.

Omnicell, Inc. is down 4.69% from its previous closing price of $37.110.

During the last market session, Omnicell, Inc.’s stock traded between $35.160 and $37.160. Currently, there are approximately 45.32 million shares outstanding for Omnicell, Inc..

Omnicell, Inc.’s price-earnings (P/E) ratio is currently at 80.4, which is high compared to the Health Care Equipment & Supplies industry median of 31.1. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Omnicell, Inc. Stock Price History

Omnicell, Inc.’s (OMCL) price is currently down 14.81% so far this month.

During the month of July, Omnicell, Inc.’s stock price has reached a high of $48.060 and a low of $35.000.

Over the last year, Omnicell, Inc. has hit prices as high as $55.000 and as low as $29.060. Year to date, Omnicell, Inc.’s stock is down 21.92%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Omnicell, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there were 0 analysts who downgraded Omnicell, Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Omnicell, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Omnicell, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Omnicell, Inc.’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Omnicell, Inc. (OMCL) by visiting AAII Stock Evaluator.

Relative Price Strength of Omnicell, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, Omnicell, Inc. has a weighted four-quarter relative price strength of -1.03%, which translates to a Momentum Score of 49 and is considered to be Average.

Want to learn more about how Omnicell, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Omnicell, Inc. Stock Price: Bottom Line

As of July 31, 2026, Omnicell, Inc.’s stock price is $35.370, which is down 4.69% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Omnicell, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.